Case report on clopidogrel rash after coronary placement of a paclitaxol-coated stent.
Antiplatelet agents are indicated after coronary stenting to prevent stent thrombosis and these should not be inadvertently discontinued after stenting. Adverse effects from the use of these drugs may require use of alternative agents.